newsfilter
← Latest News
Business Wire·

Janux Therapeutics Appoints Janeen Doyle as Chief Corporate and Business Development Officer

Ms. Doyle brings more than two decades of corporate strategy and business development experience across biotech, pharma, and venture ecosystems Janux Therapeutics, Inc. (NASDAQ:JANX) (Janux), a clinical-stage